Treatment-free remission after first-line dasatinib discontinuation in patients with chronic myeloid leukaemia (first-line DADI trial): a single-arm, multicentre, phase 2 trial

Authors: Shinya Kimura, Jun Imagawa, Kazunori Murai, Masayuki Hino, Toshio Heike, Masaya Okada, Hideo Tanaka, Motohiro Shindo, Takashi Kumagai, Takayuki Ikezoe, Nobuhiko Uoshima, Tsutomu Sato, Reiko Watanabe, Shugo Kowata, Masaya Hayakawa, Takaaki Hosoki, Kazuhiko Ikeda, Tsutomu Kobayashi, Yasutaka Kakinoki, Tetsuo Nishimoto, Naoki Takezako, Hirohiko Shibayama, Akifumi Takaori‐Kondo, Hirohisa Nakamae, Atsushi Kawaguchi, Hiroshi Ureshino, Junichi Sakamoto, Yoji Ishida - The Lancet 2020 cited by 101